Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Talampanel (LY-300164) is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor antagonist with anti-seizure activity. Talampanel (IVAX) has neuroprotective effects in rodent stroke models.
説明 | Talampanel (LY-300164) is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor antagonist with anti-seizure activity. Talampanel (IVAX) has neuroprotective effects in rodent stroke models. |
In vivo | Talampanel (p.o.; 5 mg/kg; once a day; 2 weeks) decreases motoneuronal calcium in a mouse model of ALS [1]. |
別名 | GYKI-53773, LY-300164 |
分子量 | 337.37 |
分子式 | C19H19N3O3 |
CAS No. | 161832-65-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (296.41 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Talampanel 161832-65-1 Apoptosis Neuroscience GluR GYKI 53773 GYKI-53773 inhibit Ionotropic glutamate receptors iGluR LY300164 LY 300164 LY-300164 Inhibitor GYKI53773 inhibitor